United States · FDA National Drug Code directory
Plasbumin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-690_21a20866-f2c2-4b6d-9a3f-acd2cc1b9f4a
- Product NDC
- 13533-690
- Form
- SOLUTION
- Composition / generic term
- Albumin (Human)
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19940926
- Source listing expiry
- 20261231
Source-listed ingredients
- ALBUMIN HUMAN — 2.5 g/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (13533-690-20) / 50 mL in 1 VIAL (13533-690-21) · 13533-690-20
- 1 VIAL in 1 CARTON (13533-690-25) / 250 mL in 1 VIAL (13533-690-26) · 13533-690-25
- 1 VIAL in 1 CARTON (13533-690-27) / 500 mL in 1 VIAL (13533-690-28) · 13533-690-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →